BIIO (Bionovate Technologies) Pretax Margin %: % (As of Sep. 2021)


What is Bionovate Technologies Pretax Margin %?

Bionovate Technologies BIIO Pretax Margin % is % as of Sep. 2021.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Bionovate Technologies's Pre-Tax Income for the three months ended in Sep. 2021 was $-0.02 Mil. Bionovate Technologies's Revenue for the three months ended in Sep. 2021 was $0.00 Mil. Therefore, Bionovate Technologies's pretax margin for the quarter that ended in Sep. 2021 was %.

The historical rank and industry rank for Bionovate Technologies's Pretax Margin % or its related term are showing as below:


BIIO's Pretax Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.505
* Ranked among companies with meaningful Pretax Margin % only.

Bionovate Technologies  (OTCPK:BIIO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Bionovate Technologies Pretax Margin % Related Terms

Bionovate Technologies Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Bionovate Technologies's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionovate Technologies Pretax Margin % Chart

Bionovate Technologies Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only -6,820.00 0.00 0.00 0.00 0.00

Bionovate Technologies Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BIIO vs ABT, MDT, SYK: Pretax Margin % Comparison

For the Medical Devices subindustry, Bionovate Technologies's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionovate Technologies Pretax Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bionovate Technologies's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Bionovate Technologies's Pretax Margin % falls into.


Bionovate Technologies Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Bionovate Technologies's Pretax Margin for the fiscal year that ended in Jun. 2021 is calculated as

Pretax Margin=Pre-Tax Income (A: Jun. 2021 )/Revenue (A: Jun. 2021 )
=-0.107/0
= %

Bionovate Technologies's Pretax Margin for the quarter that ended in Sep. 2021 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2021 )/Revenue (Q: Sep. 2021 )
=-0.022/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Bionovate Technologies (BIIO) has a Pretax Margin % of % as of Sep. 2021. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Bionovate Technologies and its competitors.
Is Bionovate Technologies' Pretax Margin % too high?
Bionovate Technologies' current Pretax Margin % is %.
How does Bionovate Technologies' Pretax Margin % compare to ABT and MDT?
Bionovate Technologies' Pretax Margin % of % can be compared against companies in the Medical Devices & Instruments industry. The industry median Pretax Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Bionovate Technologies and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bionovate Technologies's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionovate Technologies stock overvalued right now?
Bionovate Technologies (BIIO) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Bionovate Technologies (BIIO), the current Pretax Margin % is % as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionovate Technologies Business Description

Address 950 W Bannock Street, Boise, ID, USA, 83702
Bionovate Technologies Corp operates in the medical devices and diagnostics sector with a focus on mobile technologies.